ArticleHormone research in paediatrics2026

Extension of the Phase 3 Trial of Somatrogon in Children with Growth Hormone Deficiency: 3 Years of Safety and Efficacy.

Renata Stawerska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.